Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (56)
Zheng Huo, LiShuo Guo, Wei Shao, Qian Ding, Yue Guo & Qian Xu. (2023) CRNDE, an enhancer RNA of prognostic value in glioma, correlates with immune infiltration: A pan-cancer analysis. European Journal of Inflammation 21, pages 1721727X2211380.
Crossref
Crossref
Jin Chai, Ning Wang, Li Chen, Jingyi Bai, Jiaman Zhang, Geng Zhang, Jiahua An, Tingting Zhang, Xingyan Tong, Yifan Wu, Mingzhou Li & Long Jin. (2023) Identification of a Novel Long Non-Coding RNA G8110 That Modulates Porcine Adipogenic Differentiation and Inflammatory Responses. International Journal of Molecular Sciences 24:23, pages 16799.
Crossref
Crossref
Qilin Wang, Junyou Zhang, Zhaoshuo Liu, Yingying Duan & Chunyan Li. (2024) Integrative approaches based on genomic techniques in the functional studies on enhancers. Briefings in Bioinformatics 25:1.
Crossref
Crossref
Chao Song, Guorui Zhang, Xinxin Mu, Chenchen Feng, Qinyi Zhang, Shuang Song, Yuexin Zhang, Mingxue Yin, Hang Zhang, Huifang Tang & Chunquan Li. (2023) eRNAbase: a comprehensive database for decoding the regulatory eRNAs in human and mouse. Nucleic Acids Research.
Crossref
Crossref
Rossella Talotta. (2023) COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives. Vaccine 41:35, pages 5182-5194.
Crossref
Crossref
Liangbo Wang, Chenlu Wei, Yu Wang, Ning Huang, Tao Zhang, Yuting Dai, Li Xue, Shaojian Lin & Zhe Bao Wu. (2023) Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors. Frontiers in Endocrinology 14.
Crossref
Crossref
Xinhao Han, Wei Tian, Lin Sun, Hongying Wang, Yan Li, Huixun Jia, Guohong Gao, Liudan Mai, Shuwen Yin, Qiuju Zhang & Yanlong Liu. (2023) Prognosis of colon cancer patients based on enhancer RNAs-related genes. Journal of Cancer Research and Clinical Oncology.
Crossref
Crossref
Ke Gao, Xiaoshun Li, Jianxin Ni, Bin Wu, Jiaheng Guo, Rui Zhang & Guojun Wu. (2023) Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer. Cancer Letters 566, pages 216247.
Crossref
Crossref
Tianjiao Zhang, Liangyu Li, Hailong Sun & Guohua Wang. (2023) DeepITEH: a deep learning framework for identifying tissue-specific eRNAs from the human genome. Bioinformatics 39:6.
Crossref
Crossref
Yungang Hu, Qingqing Yang, Shuzhou Cai, Wei Wang & Shiyin Fu. (2023) The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma. Frontiers in Genetics 14.
Crossref
Crossref
Pengfei Diao, Rong Huang, Yawei Shi, Qin Yao, Yibin Dai, Hua Yuan, Yanling Wang & Jie Cheng. (2023)
Development of a novel prognostic signature derived from enhancer
RNA
‐regulated genes in head neck squamous cell carcinoma
. Head & Neck 45:4, pages 900-912.
Crossref
Crossref
Milena Stevanovic, Natasa Kovacevic-Grujicic, Isidora Petrovic, Danijela Drakulic, Milena Milivojevic & Marija Mojsin. (2023) Crosstalk between SOX Genes and Long Non-Coding RNAs in Glioblastoma. International Journal of Molecular Sciences 24:7, pages 6392.
Crossref
Crossref
Qicheng Zhang & Ke Xu. (2023) The role of regulators of RNA m6A methylation in lung cancer. Genes & Diseases 10:2, pages 495-504.
Crossref
Crossref
Shih-Chia Yeh, Faith J. F. Cheong & Yvonne Tay. (2023) Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia. International Journal of Molecular Sciences 24:4, pages 3215.
Crossref
Crossref
Mohit Umare, Fai A. Alkathiri & Rupesh Chikhale. 2023. Molecular Docking - Recent Advances. Molecular Docking - Recent Advances.
Divya Sahu, Chen-Ching Lin & Ajay Goel. (2023) Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer. Genes 14:1, pages 137.
Crossref
Crossref
Meyer J. Friedman, Haram Lee, June-Yong Lee & Soohwan Oh. (2023) Transcriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages. Immune Network 23:1.
Crossref
Crossref
Guglielmo Bove, Ida Lettiero, Giulia Sgueglia, Nunzio Del Gaudio, Lucia Altucci & Carmela Dell’Aversana. 2023. Cancer Research: An Interdisciplinary Approach. Cancer Research: An Interdisciplinary Approach
361
388
.
Jinhui Liu, Jian Yin, Yuanyuan Wang, Lixin Cai, Rui Geng, Mulong Du, Zihang Zhong, Senmiao Ni, Xiaohao Huang, Hao Yu & Jianling Bai. (2022) A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma. Biological Procedures Online 24:1.
Crossref
Crossref
Ali Rajabi, Mehrdad Kayedi, Shiva Rahimi, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Mina Homayoonfal, Seyed Mohammad Amin Mahdian, Michael R. Hamblin, Omid Reza Tamtaji, Ali Afrasiabi, Ameneh Jafari & Hamed Mirzaei. (2022) Non-coding RNAs and glioma: Focus on cancer stem cells. Molecular Therapy - Oncolytics 27, pages 100-123.
Crossref
Crossref
Penghui Yan, Zhenyu Li, Shuyuan Xian, Siqiao Wang, Qing Fu, Jiwen Zhu, Xi Yue, Xinkun Zhang, Shaofeng Chen, Wei Zhang, Jianyu Lu, Huabin Yin, Runzhi Huang & Zongqiang Huang. (2022) Construction of the prognostic enhancer RNA regulatory network in osteosarcoma. Translational Oncology 25, pages 101499.
Crossref
Crossref
Qinyu Li, Xueyan Xiao, Bingliang Chen, Guoda Song, Kai Zeng, Beining Li, Jianping Miao, Chaofan Liu, Yang Luan & Bo Liu. (2022) A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Somayeh Panahi-Moghadam, Shokoufeh Hassani, Shirin Farivar & Faezeh Vakhshiteh. (2022) Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer. Non-Coding RNA 8:5, pages 66.
Crossref
Crossref
Yunzhe Wang, Chenyang Zhang, Yuxiang Wang, Xiuping Liu & Zhao Zhang. (2022) Enhancer RNA (eRNA) in Human Diseases. International Journal of Molecular Sciences 23:19, pages 11582.
Crossref
Crossref
Hongshi Cai, Jianfeng Liang, Yaoqi Jiang, Rukeng Tan, Chen Hou & Jinsong Hou. (2022) Integrative Analysis of N6-Methyladenosine-Related Enhancer RNAs Identifies Distinct Prognosis and Tumor Immune Micro-Environment Patterns in Head and Neck Squamous Cell Carcinoma. Cancers 14:19, pages 4657.
Crossref
Crossref
Xiulei Zhang, Qian Zhang & Guangzhi Liu. (2022) Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance. Frontiers in Genetics 13.
Crossref
Crossref
Zhicheng Xu, Chao Xu, Qionghan Wang, Shanjin Ma, Yu Li, Shaojie Liu, Shiyuan Peng, Jidong Tan, Xiaolong Zhao, Donghui Han, Keying Zhang & Lijun Yang. (2022) An enhancer RNA-based risk model for prediction of bladder cancer prognosis. Frontiers in Medicine 9.
Crossref
Crossref
Yuling Gan, Yuan Yang, Yajiao Wu, Tingdong Li, Libing Liu, Fudong Liang, Jianghua Qi, Peng Liang & Dongsheng Pan. (2022) Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma. Frontiers in Surgery 9.
Crossref
Crossref
Jorge Maruri, Fernando Martínez-Cortés, Josué Odales & Karen Manoutcharian. (2022) Genomic instability, origin and evolution of cancer, and personalized immunotherapy. Vacunas (English Edition) 23:3, pages 222-233.
Crossref
Crossref
Jorge Maruri, Fernando Martínez-Cortés, Josué Odales & Karen Manoutcharian. (2022) Inestabilidad genética, origen y evolución del cáncer y la inmunoterapia personalizada. Vacunas 23:3, pages 222-233.
Crossref
Crossref
Xiaoyun Bu, Shuang Liu, Dongsheng Wen, Anna Kan, Yujie Xu, Xuanjia Lin & Ming Shi. (2022) Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy. Molecular Therapy - Oncolytics 26, pages 226-244.
Crossref
Crossref
Runzhi Huang, Dan Huang, Siqiao Wang, Shuyuan Xian, Yifan Liu, Minghao Jin, Xinkun Zhang, Shaofeng Chen, Xi Yue, Wei Zhang, Jianyu Lu, Huizhen Liu, Zongqiang Huang, Hao Zhang & Huabin Yin. (2022) Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis. Frontiers in Genetics 13.
Crossref
Crossref
Jun Liu, Jingyi Jia, Siqiao Wang, Junfang Zhang, Shuyuan Xian, Zixuan Zheng, Lin Deng, Yonghong Feng, Yuan Zhang & Jie Zhang. (2022) Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer. Molecules 27:13, pages 4108.
Crossref
Crossref
Wei Zhang, Kegong Chen, Wei Tian, Qi Zhang, Lin Sun, Yupeng Wang, Meina Liu & Qiuju Zhang. (2022) A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes. Frontiers in Oncology 12.
Crossref
Crossref
Li Wang, Shao-quan Zhou, Yu Zhou & Jia-xi Lu. (2022) A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma. Journal of Immunology Research 2022, pages 1-18.
Crossref
Crossref
Lilin Wan, Wenchao Li, Yuan Meng, Yue Hou, Ming Chen & Bin Xu. (2022) Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects. Frontiers in Immunology 13.
Crossref
Crossref
Mingda Zhu, Jingyang Zhang, Guangyu Li & Zhenzhen Liu. (2022) ELOVL2-AS1 inhibits migration of triple negative breast cancer. PeerJ 10, pages e13264.
Crossref
Crossref
Debora Bencivenga, Emanuela Stampone, Angela Vastante, Myassar Barahmeh, Fulvio Della Ragione & Adriana Borriello. (2022) An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs. Cells 11:8, pages 1346.
Crossref
Crossref
Sara Napoli, Nicolas Munz, Francesca Guidetti & Francesco Bertoni. (2022) Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades. Cancers 14:8, pages 1978.
Crossref
Crossref
Zhenzhen Han & Wei Li. (2022) Enhancer RNA: What we know and what we can achieve. Cell Proliferation 55:4.
Crossref
Crossref
Wei Tian, Guangcan Yan, Kegong Chen, Xinhao Han, Wei Zhang, Lin Sun, Qi Zhang, Yafeng Zhang, Yan Li, Meina Liu & Qiuju Zhang. (2022) Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes. Frontiers in Oncology 12.
Crossref
Crossref
Yuan Liang, Qi Zhang, Tian Xin & Da-Lin Zhang. (2022) A four-enhancer RNA-based prognostic signature for thyroid cancer. Experimental Cell Research 412:2, pages 113023.
Crossref
Crossref
Su Zhao, Hao Jiang, Jing Liu, Dao-yuan Li, Bing Li, Qiu-rong Long, Lei Zheng & Hao Gu. (2022) Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma. Disease Markers 2022, pages 1-11.
Crossref
Crossref
Wen Tong, Liuyang Zhu, Yi Bai, Long Yang, Zirong Liu & Yamin Zhang. (2022) Enhancer RNA LINC00242-Induced Expression of PHF10 Drives a Better Prognosis in Pancreatic Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Wei Tian, Kegong Chen, Guangcan Yan, Xinhao Han, Yanlong Liu, Qiuju Zhang & Meina Liu. (2022) A Novel Prognostic Tool for Glioma Based on Enhancer RNA-Regulated Immune Genes. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Hae In Choi, Ga Yeong An, Eunyoung Yoo, Mina Baek, Jin Choul Chai, Bert Binas, Young Seek Lee, Kyoung Hwa Jung & Young Gyu Chai. (2022) Targeting of non-coding RNAs encoded by novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro. Scientific Reports 12:1.
Crossref
Crossref
Yinyu Wang, Yiting Mao, Yiran Zhao, Xianfu Yi, Guolian Ding, Chuanjin Yu, Jianzhong Sheng, Xinmei Liu, Yicong Meng & Hefeng Huang. (2021) Early-life undernutrition induces enhancer RNA remodeling in mice liver. Epigenetics & Chromatin 14:1.
Crossref
Crossref
Lin Cheng, Tong Han, Bolin Chen, Kechao Nie & Weijun Peng. (2021) TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma. BMC Cancer 21:1.
Crossref
Crossref
Guanying Feng, Tianxiao Wang, Feifei Xue, Yibo Qi, Ruixia Wang & Hua Yuan. (2021)
Identification of enhancer
RNAs
for the prognosis of head and neck squamous cell carcinoma
. Head & Neck 43:12, pages 3820-3831.
Crossref
Crossref
Tao Yan, Kai Wang, Qidi Zhao, Junjie Zhuang, Hongchang Shen, Guoyuan Ma, Lei Cong & Jiajun Du. (2021) Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening. PeerJ 9, pages e12536.
Crossref
Crossref
Yuxin Shen, Zhengyi Huang, Ruiqing Yang, Yunlong Chen, Qiang Wang & Linbo Gao. (2021) Insights into Enhancer RNAs: Biogenesis and Emerging Role in Brain Diseases. The Neuroscientist, pages 107385842110468.
Crossref
Crossref
Santanu Adhikary, Siddhartha Roy, Jessica Chacon, Shrikanth S. Gadad & Chandrima Das. (2021) Implications of Enhancer Transcription and eRNAs in Cancer. Cancer Research 81:16, pages 4174-4182.
Crossref
Crossref
Joo-Hyung Lee, Ruoyu Wang, Feng Xiong, Joanna Krakowiak, Zian Liao, Phuoc T. Nguyen, Elena V. Moroz-Omori, Jiaofang Shao, Xiaoyu Zhu, Michael J. Bolt, Haoyi Wu, Pankaj K. Singh, Mingjun Bi, Caleb J. Shi, Naadir Jamal, Guojie Li, Ragini Mistry, Sung Yun Jung, Kuang-Lei Tsai, Josephine C. Ferreon, Fabio Stossi, Amedeo Caflisch, Zhijie Liu, Michael A. Mancini & Wenbo Li. (2021) Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Molecular Cell 81:16, pages 3368-3385.e9.
Crossref
Crossref
Linbang Wang, Jingkun Liu, Jiaojiao Tai, Nian Zhou, Tianji Huang, Yuzhou Xue & Zhengxue Quan. (2021) A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer. Scientific Reports 11:1.
Crossref
Crossref
Tian Hua, Yun-jie Tian, Rui-min Wang, Cai-fen Zhao, Yun-hong Kong, Rui-qing Tian, Wei Wang & Li-xia Ma. (2021) FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer. Bioscience Reports 41:4.
Crossref
Crossref
Ke Fang, Wei Huang, Yu-Meng Sun, Tian-Qi Chen, Zhan-Cheng Zeng, Qian-Qian Yang, Qi Pan, Cai Han, Lin-Yu Sun, Xue-Qun Luo, Wen-Tao Wang & Yue-Qin Chen. (2020) Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression. Genome Biology 21:1.
Crossref
Crossref